Plural CEO system favored in 21 drug firms

Published: 2013-04-04 06:56:00

Updated: 2013-04-04 06:56:00

Twenty one of 56 pharmaceutical companies have adopted the system of more than two chief executive officers (CEO) to ensure more efficient company management, according to Yakup.com, a pharmaceutical information website.

These companies include Daewooong Pharm, Green Cross, Corp., Hanmi Pharm,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK